
- Applied Clinical Trials-03-01-2007
- Volume 0
- Issue 0
eShowcase: Liquent InSight v. 3.5
Dual-purpose package allows submission in both paper and electronic formats
Dual-purpose package allows submission in both paper and electronic formats
Thomson Scientific (Philadelphia, PA, and London, UK) recently released the latest version of its regulatory compliance tool, InSight Publisher version 3.5. The latest iteration enables pharmaceutical companies to create, manage, and publish regulatory submissions in both paper and electronic form using a single software application, potentially saving critical time in the drug development process.
Around the world, regulatory authorities increasingly prefer the electronic format, yet they still require a paper version. With Liquent InSight version 3.5, life science professionals can produce both from a single assembly, using the same thin-client application integrated with the rest of the InSight software suite. Since it is built on the same platform as InSight Manager, which offers registration management and submission tracking capabilities, the entire platform is highly adaptable to different organizational processes and designs.
Thomson Scientific, (215) 386-0100,
Articles in this issue
over 18 years ago
Europe's Pediatric Rules in Force—At Lastover 18 years ago
Pressure Mounts to Streamline Trialsover 18 years ago
Is Something Better than Nothing?over 18 years ago
Promoting Clinical Trials in Japanover 18 years ago
eShowcase: Business Services Dashboardover 18 years ago
eShowcase: Clin'Formover 18 years ago
The Critical Path Initiative Meets Medical Devicesover 18 years ago
Taking Computers into the Next Virtual Realmover 18 years ago
Blinded by Science with Adaptive Designsover 18 years ago
Increase Your Company's Value with EDMNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.